These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3666078)

  • 1. The deafferentation syndrome in the rat: effects of intraventricular neurotensin and cholecystokinin.
    Rossitch E; Ovelmen-Levitt J; Lyerly MA; Nashold BS
    Exp Neurol; 1987 Nov; 98(2):264-75. PubMed ID: 3666078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The deafferentation syndrome in the rat: effects of intraventricular apomorphine.
    Lyerly MA; Rossitch E; Ovelmen-Levitt J; Nashold BS
    Exp Neurol; 1988 Apr; 100(1):188-202. PubMed ID: 3350088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of deafferentation dysesthesias reduced by dorsal root entry zone lesions in the rat.
    Rossitch E; Abdulhak M; Ovelmen-Levitt J; Levitt M; Nashold BS
    J Neurosurg; 1993 Apr; 78(4):598-602. PubMed ID: 8450334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of stereotactically applied neuromodulators on the deafferentation syndrome in rats.
    Rossitch E; Lyerly MA; Ovelmen-Levitt J; Nashold BS
    Appl Neurophysiol; 1987; 50(1-6):418-9. PubMed ID: 3329878
    [No Abstract]   [Full Text] [Related]  

  • 5. Intraventricular injection of neurotensin reduces dopamine D2 agonist binding in rat forebrain and intermediate lobe of the pituitary gland. Relationship to serum hormone levels and nerve terminal coexistence.
    von Euler G; Meister B; Hökfelt T; Eneroth P; Fuxe K
    Brain Res; 1990 Oct; 531(1-2):253-62. PubMed ID: 1981163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity studies of neurotensin on muscular rigidity and tremors induced by 6-hydroxydopamine lesions in the posterolateral hypothalamus of the rat.
    Rivest R; St-Pierre S; Jolicoeur FB
    Neuropharmacology; 1991 Jan; 30(1):47-52. PubMed ID: 1904561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo neurochemical and behavioural effects of intracerebrally administered neurotensin and D-Trp11-neurotensin on mesolimbic and nigrostriatal dopaminergic function in the rat.
    Ford AP; Marsden CA
    Brain Res; 1990 Nov; 534(1-2):243-50. PubMed ID: 2073584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deafferentation syndrome in the rat: effects of sex, age, and lesion type.
    Rossitch E; Lyerly MA; Ovelmen-Levitt J; Young JN; Nashold BS
    Surg Neurol; 1992 Feb; 37(2):89-93. PubMed ID: 1546382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cyclic AMP content of the blood, brain, stomach, adrenals and duodenum after administration of neurotensin and cholecystokinin].
    Andreanova MV; Vasil'ev VIu; Ardemasova ZA
    Fiziol Zh SSSR Im I M Sechenova; 1985 Feb; 71(2):258-61. PubMed ID: 2985456
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of amfonelic acid to discriminate between classical and atypical neuroleptics and neurotensin: an in vivo voltammetric study.
    Rivest R; Jolicoeur FB; Marsden CA
    Brain Res; 1991 Mar; 544(1):86-93. PubMed ID: 1677303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central nervous system neurotensin and feeding.
    Hawkins MF
    Physiol Behav; 1986 Jan; 36(1):1-8. PubMed ID: 3952166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholecystokinin and neurotensin inversely modulate excitatory synaptic transmission in the parabrachial nucleus in vitro.
    Saleh TM; Kombian SB; Zidichouski JA; Pittman QJ
    Neuroscience; 1997 Mar; 77(1):23-35. PubMed ID: 9044371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of glucagon, Neurotensin, and vasoactive intestinal polypeptide on somatostatin release from perifused rat hypothalamus.
    Shimatsu A; Kato Y; Matsushita N; Katakami H; Yanaihara N; Imura H
    Endocrinology; 1982 Jun; 110(6):2113-7. PubMed ID: 6122561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cholecystokinin, neurotensin and corticotropin-releasing factor, three important anorexic peptides].
    Beck B
    Ann Endocrinol (Paris); 1992; 53(1):44-56. PubMed ID: 1444178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptides and self-stimulation of the medial prefrontal cortex in the rat: effects of intracerebral microinjections of substance P and cholecystokinin.
    Ferrer JM; Cobo M; Mora F
    Peptides; 1988; 9(5):937-43. PubMed ID: 2469066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracerebroventricular administration of cholecystokinin inhibits the activity of the dopaminergic and serotoninergic systems of the brain.
    Vasar EE; Otter MYa ; Ryago LK
    Neurosci Behav Physiol; 1985; 15(3):232-6. PubMed ID: 2993947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of microinjections of cholecystokinin and neurotensin into lateral hypothalamus and ventral mesencephalon on intracranial self-stimulation.
    Singh J; Desiraju T; Raju TR
    Pharmacol Biochem Behav; 1997 Dec; 58(4):893-8. PubMed ID: 9408192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of neurotensin receptor activation on brain stimulation reward in Fischer 344 and Lewis rats.
    Bauco P; Rompré PP
    Eur J Pharmacol; 2001 Nov; 432(1):57-61. PubMed ID: 11734188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of neurotensin, cholecystokinin, and secretin in the stimulation of the exocrine pancreas in the dog.
    Baća I; Feurle GE; Haas M; Mernitz T
    Gastroenterology; 1983 Mar; 84(3):556-61. PubMed ID: 6295872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiparkinson-like effects of neurotensin in 6-hydroxydopamine lesioned rats.
    Jolicoeur FB; Rivest R; St-Pierre S; Drumheller A
    Brain Res; 1991 Jan; 538(2):187-92. PubMed ID: 1901504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.